Confluent Medical Technologies Names Matthew K. Eckl as Chief Financial Officer
Copyright 2022, Business Wire.
news
2022-10-17 19:05:00

October 17, 2022 03:05 PM Eastern Daylight Time SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Confluent Medical Technologies, Inc. ('Confluent') today announced that Matthew K. Eckl has been appointed as Chief Financial Officer ("CFO") for the company, effective October 17, 2022.



"We are thrilled to welcome Matt to Confluent," said Dean Schauer, Confluent's Chief Executive Officer. "Matt has exceptional experience in finance and financial operations as well as leadership across a variety of design and manufacturing organizations.
